Masimo宣布,搭载无创血压测量功能的Rad-97™ 脉搏碳氧-氧饱和度仪®和互通接口获得CE标记
瑞士纳沙泰尔 (美国商业资讯)– Masimo (NASDAQ: MASI)今天宣布,搭载无创血压(NIBP)测量功能的Rad-97™脉搏碳氧-氧饱和度仪®和互通接口获得CE标记。Rad-97在一个紧凑的单体监护仪配置中提供移动和低灌注下测量(Measure-through Motion and Low...
View Articleマシモ、非観血血圧測定が可能なRad-97™ Pulse CO-Oximeter®と接続ハブでCEマークを取得したと発表
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Rad-97™ Pulse CO-Oximeter®と接続ハブによる非観血血圧(NIBP)測定機能でCEマークを取得したと発表しました。Rad-97はMeasure-through Motion and Low...
View ArticleAlexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential...
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced today that it has submitted an application to Japan’s Ministry of Labour and Welfare (MHLW) to extend the indication for...
View ArticleWatts Sponsors Water Filtration Tower at Elementary School in the Philippines...
NORTH ANDOVER, Mass. Watts Water Technologies, Inc. (NYSE: WTS) today announced its sponsorship of a water filtration system at the Pantay Elementary School in the village of Pantay Matanda, the...
View ArticleGI Dynamics to Release 2016 Annual Report and Host Webcast for Year Ending 31...
BOSTON & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company that has commercialized EndoBarrier® in Europe and the Middle East for patients with type 2 diabetes and obesity, announced...
View Articleフェリング・ファーマシューティカルズ:夜中のトイレ起きは質の悪い睡眠の最大の原因であると専門家らが世界睡眠デーで指摘
スイス・サンプレ (ビジネスワイヤ) — 「世界睡眠デー」に当たり、睡眠の専門家らは人々に対し、健康で充実した睡眠の価値を理解するよう喚起しています。特に夜間に1回以上トイレに行く必要がある場合は夜間頻尿と見なされますが、30歳超の成人の3人に1人、65歳超の成人の3分の2がこの症状を患っています1。 「夜間頻尿リソースセンター」の編集者でマーストリヒト大学泌尿器科教授のPhilip Van...
View ArticleHeliae Announces First Use of Branded TruAzta Natural Astaxanthin
GILBERT, Ariz. Heliae, in collaboration with Madre Labs Inc., today announced California GOLD Nutrition Astaxanthin supplement caps branded with a TruAzta™ logo are now available on iHerb.com. This...
View ArticleHeliae宣布首次使用TruAzta品牌的天然虾青素
亚利桑那州吉尔伯特 (美国商业资讯) — Heliae与Madre Labs Inc.合作,今天宣布,现已在iHerb.com上使用TruAzta™标识品牌发售California GOLD Nutrition虾青素补剂胶囊。 Smart News Releases(智能新闻稿)是一个多媒体平台。在此处查看完整新闻稿:...
View ArticleTakeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that data from a 6-month interim analysis* of the ongoing DEN-204 trial of its live-attenuated tetravalent...
View Articleヘリエ、TruAztaブランド天然アスタキサンチンの初の使用例を発表
米アリゾナ州ギルバート (ビジネスワイヤ) — ヘリエは本日、マドレラブズと共同で、TruAzta™ロゴでブランド化したカリフォルニアゴールドニュートリション・アスタキサンチンのサプリメント・カプセルがiHerb.comで購入可能になったと発表しました。 このSmart News...
View ArticleEstablishment of Mitsui Chemicals Thailand
TOKYO Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: Tsutomu Tannowa) announced that it established Mitsui Chemicals (Thailand) Co., Ltd. in Bangkok, Thailand on April 3, 2017. With...
View ArticleEuromonitor International to Donate Over One Million Pounds in New CSR Programme
LONDON Market Research Company Euromonitor International launched today a new Corporate Social Responsibility (CSR) programme donating one percent of its turnover, equivalent to over £1 million, to...
View ArticleLombard Medical and MicroPort Scientific Corporation Finalize Strategic...
OXFORDSHIRE, U.K. & SHANGHAI Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading...
View ArticleSES and Luxembourg Government Extend SATMED E-Health Contract
LUXEMBOURG SES (Euronext Paris:SESG) (LuxX:SESG) and the Luxembourg Ministry of Foreign and European Affairs today announced that they have extended a contract to maintain and support SATMED, an...
View ArticleFinch Therapeutics and Takeda Announce Global Collaboration to Develop...
OSAKA, Japan & SOMERVILLE, Mass. Finch Therapeutics, a privately held microbiome engineering company, and Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), today announced a global...
View ArticleTakeda Completes Enrollment of More Than 20,000 Children and Adolescents in...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16 in its global,...
View Article患者安全运动基金会宣布第三届患者安全创新年度奖开放申请
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)宣布,第三届患者安全创新年度奖将于太平洋夏令时2017年4月3日中午...
View ArticleU.S. FDA Approves Increased Compassionate Use Patient Cases and Sites for...
VALENCIA, Calif. & PERTH, Australia & LONDON The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the...
View Article